Stephen F. Betz has sold CRNX and made no open-market buys since Oct 2021
Chief Scientific Officer at Crinetics Pharmaceuticals, Inc.
SEC CIK 0001886575 · Filings on SEC.gov ↗
Every filing
44 filings since Oct 2021, newest first
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
Crinetics Pharmaceuticals, Inc.
Chief Scientific Officer
About Stephen F. Betz
Stephen F. Betz, Ph.D., is a Person and a co-founder of Crinetics Pharmaceuticals, where he currently serves as Chief Scientific Officer.( He has been with Crinetics since its inception in 2008 and previously served as Vice President of Biology before taking on his current role.(
Betz has extensive experience in pharmaceutical and biotechnology drug discovery. Before Crinetics, he was Director of Endocrinology and Metabolism at Neurocrine Biosciences, where he worked on gonadotropin-releasing hormone receptor antagonists and other endocrine targets; earlier, he led laboratory efforts at GeneFormatics and worked in pharmaceutical discovery at Abbott Laboratories on structure-guided drug design, assay development, and compound screening.( He holds a B.S. in chemistry from the University of Delaware and a Ph.D. in chemistry from the University of North Carolina at Chapel Hill.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.